参考文献/References:
[1]路爱梅,李洪峥,杨文文,等.山楂-鸡血藤通过mTOR-自噬-溶酶体通路抗动脉粥样硬化机制研究[J].陕西中医,2026,47(2):154-160.
[2]XU J W,TIAN Z H,LI Z,et al.Puerarin-Tanshinone ⅡA suppresses atherosclerosis inflammatory plaque via targeting succinate/HIF-1α/IL-1β axis[J].J Ethnopharmacol,2023,317:116675.
[3]ZHANG Y,WANG J,YANG S,et al.Tanshinone ⅡA alleviate atherosclerosis and hepatic steatosis via down-regulation of MAPKs/NF-κB signaling pathway[J].Int Immunopharmacol,2025,152:114465.
[4]KAKIZAKI R,BAR S,RABER L.Targeting vulnerable plaques in coronary artery disease:Detecting risk,preventing events[J].Curr Cardiol Rep,2025,27(1):166.
[5]HOU P,FANG J,LIU Z,et al.Macrophage polarization and metabolism in atherosclerosis[J].Cell Death Dis,2023,14(10):691.
[6]LIU L,AN Z,ZHANG H,et al.Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK/mTOR pathway-mediated autophagy-related macrophage polarization[J].Cardiovasc Diabetol,2025,24(1):48.
[7]KAVANAGH M,HERRERO D I,PRIETO I,et al.Opposing functions of miR-155-5p and SOCS1 drive vascular inflammation in diabetes-accelerated atherosclerosis[J].Cardiovasc Diabetol,2026,25(1):106.
[8]PARA D,ROY S,ARORA L,et al.miR-210-3p promotes obesity-induced adipose tissue inflammation and insulin resistance by targeting SOCS1 mediated NF-κB pathway[J].Diabetes,2023,72(3):375-388.
[9]张双丽,葛诗慧,葛梓萌,等.复方丹参滴丸改善高脂血症ApoE-/-小鼠动脉粥样硬化的作用机制[J].中国新药杂志,2025,34(23):2552-2564.
[10]陶叶琴,刘辉,高明果,等.基于“痰瘀互结”理论的丹楂通脉丸抗动脉粥样硬化作用机制研究[J].中国中药杂志,2026(4):1099-1109.
[11]WANG X,ZHENG K,ZHANG Q.Assessment of the association between constipation and atherosclerosis in cardiovascular and cerebrovascular diseases:A systematic review and meta-analysis[J].Am J Med Sci,2025,370(2):118-128.
[12]曾义迦,宋敏,喻虹.2型糖尿病患者血清微小RNA-155和核苷酸结合寡聚结构域样受体蛋白3水平变化及对颈动脉粥样硬化的诊断价值[J].中国医药,2024,19(9):1347-1352.
[13]万琴.咖啡酸对硝基苯乙酯下调miR-155抑制动脉粥样硬化的研究[D].重庆:西南大学,2022.
[14]YANG W W,LI Q X,WANG F,et al.Exosomal miR-155-5p promote the occurrence of carotid atherosclerosis[J].J Cell Mol Med,2024,28(21):e70187.
[15]何德全.丹参酮ⅡA通过调控Hippo-YAP信号通路改善动脉粥样硬化炎症反应[D].广州:南方医科大学,2023.
[16]YANG C,MU Y,LI S,et al.Tanshinone ⅡA:A Chinese herbal ingredient for the treatment of atherosclerosis[J].Front Pharmacol,2023,14:1321880.
[17]KONG P,CUI Z Y,HUANG X F,et al.Inflammation and atherosclerosis:Signaling pathways and therapeutic intervention[J].Signal Transduct Target Ther,2022,7(1):131.
[18]张艳红,秦英,邵刚.化痰通络方对高血压颈动脉粥样硬化斑块易损性的影响[J].中国实验方剂学杂志,2023,29(19):151-159.
[19]谢佳佳,廖文君,吴碧君,等.秋水仙碱对动脉粥样硬化小鼠主动脉斑块的干预作用及对核苷酸结合寡聚化结构域样受体3/含CARD结构域的凋亡相关颗粒样蛋白/含半胱氨酸的天冬氨酸蛋白酶1信号通路、炎症反应的影响[J].陕西医学杂志,2025,54(10):1324-1330.
[20]LIU W,WANG J,YANG H,et al.The metabolite indole-3-acetic acid of bacteroides ovatus improves atherosclerosis by restoring the polarisation balance of M1/M2 macrophages and inhibiting inflammation[J].Adv Sci (Weinh),2025,12(11):e2413010.
[21]WANG X,DU H,LI X.Artesunate attenuates atherosclerosis by inhibiting macrophage M1-like polarization and improving metabolism[J].Int Immunopharmacol,2022,102:108413.
[22]JAFARZADEH A,GURJAR D,BODHALE N,et al.Aberrant expression of SOCS impairs the anti-leishmanial immune response[J].Cytokine,2024,174:156461.
[23]XU L,ZHANG H,WANG Y,et al.FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE-/- mice atherosclerosis[J].Lab Invest,2022,102(1):25-37.
[24]NIE W,GONG C,LIU Y,et al.AMPK upregulates SOCS1 to promote TFEB nuclear transfer,enhances autophagy,inhibits macrophage M1 polarization and relieves acute lung injury[J].Mol Immunol,2025,187:240-253.
相似文献/References:
[1]陈文璐,张 婧,徐晓辉△.加倍剂量阿托伐他汀钙对稳定型心绞痛患者血清[J].陕西医学杂志,2018,(12):1548.
[2]赵红敏,袁山旗△,庞苗苗.颈动脉多普勒彩色超声联合脂联素和白细胞介素8检测在动脉粥样硬化中应用价值研究[J].陕西医学杂志,2019,(1):64.
[3]张 喆,马 鹏.幽门螺旋杆菌感染与动脉粥样硬化关系的研究进展[J].陕西医学杂志,2019,(2):270.
[4]李卫国,韩 晶,陶 凌,等.血流储备临界值时单纯左前降支中度狭窄患者治疗方案临床研究[J].陕西医学杂志,2021,50(4):450.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.017]
LI Weiguo,HAN Jing,TAO Ling,et al.The choice of treatment scheme of critical value of blood flow reserve in patients with moderate stenosis of left anterior descending artery[J].,2021,50(9):450.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.017]
[5]乔冰冰,庞世杰,王海叶.丹参酮ⅡA对人喉癌Hep-2细胞增殖和细胞周期的影响及机制研究[J].陕西医学杂志,2023,52(8):960.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.004]
QIAO Bingbing,PANG Shijie,WANG Haiye.Effects of Tanshinone ⅡA on proliferation and cell cycle of human laryngeal carcinoma Hep-2 cells and its mechanism[J].,2023,52(9):960.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.004]
[6]何春艳,裴美娟,李玉明,等.发状分裂增强子1对胆固醇刺激下内皮细胞的影响及机制研究[J].陕西医学杂志,2023,52(9):1115.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.001]
HE Chunyan,PEI Meijuan,LI Yuming,et al.Effect and mechanism of HES-1 on cholesterol stimulated endothelial cells[J].,2023,52(9):1115.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.001]
[7]贾小慧,王泽宇,田嘉莹,等.丹参酮ⅡA通过抑制细胞色素P450 1B1/长链酰基辅酶A合成酶4通路介导铁死亡缓解缺血性脑卒中[J].陕西医学杂志,2025,54(7):882.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.003]
JIA Xiaohui,WANG Zeyu,TIAN Jiaying,et al.Tanshinone ⅡA alleviates ischemic stroke by suppressing cytochrome P450 1B1/acyl-CoA synthetase long-chain family member 4 (CYP1B1/ACSL4)-mediated ferroptosis[J].,2025,54(9):882.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.003]
[8]张国安,石践,宋宝国,等.囊泡相关膜蛋白8通过激活AMP活化蛋白激酶/哺乳动物雷帕霉素靶蛋白介导自噬促进动脉粥样硬化研究[J].陕西医学杂志,2025,54(7):899.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.006]
ZHANG Guoan,SHI Jian,SONG Baoguo,et al.VAMP8 promotes atherosclerosis progression through the AMPK-mTOR pathway mediated autophagy[J].,2025,54(9):899.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.006]
[9]李震,晋群.炎症在冠心病发生发展中的作用及抗炎治疗研究进展[J].陕西医学杂志,2025,54(7):1001.[doi:DOI:10.3969/j.issn.1000-7377.2025.07.026]
[10]谢佳佳,廖文君,吴碧君,等.秋水仙碱对动脉粥样硬化小鼠主动脉斑块的干预作用及对核苷酸结合寡聚化结构域样受体3/含CARD结构域的凋亡相关颗粒样蛋白/含半胱氨酸的天冬氨酸蛋白酶1信号通路、炎症反应的影响[J].陕西医学杂志,2025,54(10):1324.[doi:DOI:10.3969/j.issn.1000-7377.2025.10.005]
XIE Jiajia,LIAO Wenjun,WU Bijun,et al.Intervention effect of colchicine on aortic plaque in atherosclerosis mice and the influence on NLRP3/ASC/Caspase-1 signal pathway and inflammatory response[J].,2025,54(9):1324.[doi:DOI:10.3969/j.issn.1000-7377.2025.10.005]